Table 1. The possible relationship between RAS components and AMPK.
Components of RAS | Tissue or cell type | Relation to AMPK | Related studies | |
---|---|---|---|---|
ACE | Heart | No direct relation was shown | [77–79] | |
Vascular system endothelial cells |
AMPKα2 suppresses endothelial ACE expression via the phosphorylation of p53 and up-regulation of miR-143/145 | [75] | ||
Monocytes | ACE expression was reduced in spleen derived-monocytes from AMPKα1(−/−) mice versus their wild-type littermates | [74] | ||
White adipose tissue | AMPK may decrease ACE expression | [76] | ||
AngII | Heart | Rat neonatal cardiomyocytes | AngII down-regulates AMPK (α-Thr172) may be by phosphorylating α-Ser485/491 or inhibiting LKB1 | [78,84–86] |
Neonatal rat ventricular myocytes (NRVMs) | Activation of AMPK can ameliorate pathological damage induced by AngII | [103,108] | ||
H9C2 cells neonatal rat cardiomyocyte (NRCMs) | No direct relation was shown | [88,89] | ||
HL-1 atrial myocytes | Ang ІІ decreased oxygen consumption rate, which resulted in ROS generation, AngII-induced intracellular calcium production. The generated ROS and calcium stimulated AMPK phosphorylation. Inhibiting AMPK blocked AngII-mediated JNK and TGF-β signaling pathways | [90] | ||
AngII | Vascular system | VSMCs | AngII-induced AMPK activation and that AMPK works as an inhibitor of the AngII proliferative pathway | [91] |
VSMCs | AngII led to minor activation of AMPK at a low concentration (0.1–1 μM), whereas AngII suppressed AMPKα activity at a high concentration (5 μM) AngII could elevate LKB1 expression in VSMCs, while the activity of LKB1 was not elevated with the expression of LKB1, even declined slightly |
[92–94] | ||
VSMC human umbilical vein endothelial cells (HUVECs) |
Activation of AMPK can ameliorate pathological damage induced by AngII | [104–107,109] | ||
AngII | Skeletal muscle | AngII inhibits AMPK Thr172 and AngII might up-regulate the AMPK resistance | [97,109] | |
Kidney | AngII inhibits AMPK by binding to AT1 p-AMPK increase after ARB application | [100–102,105] | ||
AT1R | Heart | AT1 is negatively related to AMPK, ARB could phosphorylate AMPK | [112,113,117] | |
Skeletal muscle |
ARB can improve AMPK resistance and activate AMPK | [97–99] | ||
AT2R | White adipocytes | AT2R may activate AMPK independent of AngII | [119] | |
Pulmonary artery endothelial cells (PAECs) | By binding to AT2R, AngII induces apoptosis by phosphorylating AMPK β | [120,121] | ||
Chinese hamster ovary (CHO)-K1 cells | Both AT1R and AT2R overexpression activated AMPK | [120] | ||
ACE2 | Heart | ACE2 could activate AMPK | [85,123,124] | |
Adipose tissue | Phosphorylation of AMPK is reduced when ACE2 is knocked out | [124] | ||
Huh7 (hepatocellular carcinoma-derived) cells | AMPK activation can increase ACE2 expression, but this effect requires sirtuin 1 (SIRT1) to participate | [76,125] | ||
HUVECs and human embryonic kidney 293 (HEK293T) cells | Phosphorylated ACE2 Ser680 by AMPK could enhance the ACE2 stability | [126] | ||
Ang(1-7) | Vascular systemaortas versus aortic tissues | Ang(1-7) could activate AMPK | [124,131] | |
White adipose tissue | Ang(1-7) could activate AMPK | [76] | ||
MasR | Adipose tissue | MasR may be positively related to AMPK | [76,124] | |
MrgD | Ventricular cardiomyocytes | Almandine could activate AMPK by activating LKB1 | [89] |